Log in
Enquire now

Clinical Studies Sponsored by Celltrion

Clinical Studies Sponsored by Celltrion
Clinical Studies Sponsored by University of Cincinnati
Clinical Studies Sponsored by Tel Aviv University
Clinical Studies Sponsored by University of South Florida
List of companies in Borun Capital's investment portfolio
List of SBIR/STTR awards granted to Targazyme, Inc.
Clinical Studies where
Trial Sponsor
is
Name
Description
NCT Number
Health Conditions in Trial
Clinical Trial Start Date
Study Completion Date
Clinical Trial Study Type
‌
Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in RA Patients(PLANETRA)

NCT01217086
Rheumatoid arthritis
Rheumatoid arthritis
2010
2012
Interventional
‌
An Extension Study to Demonstrate the Equivalence of Long-Term Efficacy and Safety of CT-P13 in Patients With Ankylosing Spondylitis Who Were Treated With Infliximab (Remicade or CT-P13) in Study CT-P13 1.1

NCT01571206
Ankylosing spondylitis
Ankylosing spondylitis
2012
2013
Interventional
‌
Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in AS Patients(PLANETAS)

NCT01220518
Ankylosing spondylitis
Ankylosing spondylitis
2010
2012
Interventional
‌
A Study to Compare Efficacy and Safety of CT-P55 and Cosentyx in Patients with Moderate to Severe Psoriasis

NCT06630559
2025
2026
Interventional
‌
To Evaluate the Safety and Efficacy of Remsima™ in Patients With Crohn's Disease (CD) or Ulcerative Colitis (UC)

NCT02326155
Crohn's disease
Crohn's disease
Ulcerative colitis
Ulcerative colitis
December 8, 2014
February 28, 2020
Observational
‌
An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With Ankylosing Spondylitis

NCT02557308
Ankylosing spondylitis
Ankylosing spondylitis
2014
2026
Observational
‌
An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With RA

NCT02557295
Rheumatoid arthritis
Rheumatoid arthritis
2013
2026
Observational
‌
A Phase I/III Study to Evaluate Efficacy, PK and Safety Between CT-P13 SC and CT-P13 IV in Patients With Active RA

NCT03147248
Rheumatoid arthritis
Rheumatoid arthritis
September 12, 2016
April 15, 2019
Interventional
‌
To Demonstrate Equivalence of Pharmacokinetics and Noninferiority of Efficacy for CT-P10 in Comparison With Rituxan

NCT02162771
July 14, 2014
December 29, 2018
Interventional
‌
A Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous in Patients With Active Crohn's Disease and Ulcerative Colitis

NCT02883452
Crohn's disease
Crohn's disease
September 29, 2016
October 2, 2019
Interventional
‌
A Study to Evaluate the Efficacy and Safety of CT-P27 in an Influenza Challenge Model

NCT02071914
February 15, 2014
June 19, 2014
Interventional
‌
A Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients With Relapsing-remitting Multiple Sclerosis

NCT05906992
2023
2029
Interventional
‌
To Compare Efficacy and Safety Between CT-P10 and Rituxan in Patients With Low Tumour Burden Follicular Lymphoma

NCT02260804
‌
Follicular lymphoma
November 9, 2015
September 4, 2019
Interventional
‌
This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19)

NCT04593641
September 4, 2020
April 5, 2021
Interventional
‌
Demonstrate Efficacy and Safety of Metastatic Breast Cancer

NCT01084876
Metastatic breast cancer
Metastatic breast cancer
2010
2017
Interventional
‌
Study to Compare PK and Safety of Subcutaneous Injection of Ustekinumab and CT-P43 in Healthy Subjects

NCT04428814
August 3, 2020
February 24, 2021
Interventional
‌
PK Similarity Prospective Phase 3 Study in Patients With Rheumatoid Arthritis

NCT02149121
Rheumatoid arthritis
Rheumatoid arthritis
2014
2017
Interventional
‌
A Drug-Drug Interaction Study of CTL0901 and CTL0902 Compared to Coadministration in Healthy Adult Volunteers

NCT05009368
July 23, 2021
October 15, 2021
Interventional
‌
A Study to Compare Efficacy and Safety of CT-P17 With Humira in Patients With Active Rheumatoid Arthritis

NCT03789292
Rheumatoid arthritis
Rheumatoid arthritis
November 26, 2018
April 24, 2020
Interventional
‌
A Study to Evaluate the Safety of Remsima® SC in the Treatment of RA, AS, PsA and Ps

NCT05866614
Rheumatoid arthritis
Rheumatoid arthritis
Psoriasis
Psoriasis
Ankylosing spondylitis
Ankylosing spondylitis
‌
Psoriatic arthritis
January 13, 2023
2027
Observational
‌
To Compare Efficacy and Safety of CT-P16 and EU-Approved Avastin as First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer

NCT03676192
December 19, 2018
2023
Interventional
‌
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 or CT-G11 and Food Effect of CT-G20 in Human Participants

NCT03918967
‌
Healthy
April 8, 2019
June 6, 2020
Interventional
‌
To Compare Efficacy and Safety of CT-P39 and EU-approved Xolair in Patients With Chronic Spontaneous Urticaria

NCT04426890
December 9, 2020
April 27, 2023
Interventional
‌
Study to Compare Efficacy and Safety of CT-P42 in Comparison With Eylea in Patients With Diabetic Macular Edema

NCT04739306
July 22, 2021
April 24, 2023
Interventional
‌
A Bioequivalence Study of L04TD2 Compared to Administration of L04RD1 in Healthy Volunteers

NCT05581693
‌
Healthy
September 30, 2022
November 29, 2022
Interventional
Results per page:
58 results
0 selected
58 results
0 selected
Golden logo

Company

  • Home
  • Pricing
  • Become an Editor
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us

Explore companies

  • Artificial Intelligence
  • Fintech
  • Biotechnology
  • Cybersecurity
  • Semiconductors
  • Electric Vehicles
  • Cloud Computing
  • Robotics
  • SaaS
  • Renewable Energy
  • Venture Capital
  • Blockchain
  • Browse all →